GE HEALTHCARE TECHNOLOGIES ($GEHC) posted quarterly earnings results on Wednesday, October 29th. The company reported earnings of $1.07 per share, missing estimates of $1.07 by $0.00. The company also reported revenue of $5,143,000,000, missing estimates of $5,176,879,287 by $-33,879,287.
You can see Quiver Quantitative's $GEHC stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
GE HEALTHCARE TECHNOLOGIES Hedge Fund Activity
We have seen 563 institutional investors add shares of GE HEALTHCARE TECHNOLOGIES stock to their portfolio, and 642 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL RESEARCH GLOBAL INVESTORS removed 31,220,666 shares (-61.0%) from their portfolio in Q2 2025, for an estimated $2,312,514,730
- DODGE & COX added 6,982,441 shares (+42.1%) to their portfolio in Q2 2025, for an estimated $517,189,404
- HARRIS ASSOCIATES L P added 4,038,491 shares (+71.7%) to their portfolio in Q2 2025, for an estimated $299,131,028
- JANE STREET GROUP, LLC added 3,178,470 shares (+1584.1%) to their portfolio in Q2 2025, for an estimated $235,429,272
- MIZUHO MARKETS AMERICAS LLC added 2,609,000 shares (+inf%) to their portfolio in Q2 2025, for an estimated $193,248,629
- HOLOCENE ADVISORS, LP added 2,581,522 shares (+178.5%) to their portfolio in Q2 2025, for an estimated $191,213,334
- CITADEL ADVISORS LLC added 2,383,389 shares (+34.5%) to their portfolio in Q2 2025, for an estimated $176,537,623
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
GE HEALTHCARE TECHNOLOGIES Congressional Stock Trading
Members of Congress have traded $GEHC stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $GEHC stock by members of Congress over the last 6 months:
- REPRESENTATIVE ROBERT BRESNAHAN purchased up to $15,000 on 05/15.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
GE HEALTHCARE TECHNOLOGIES Analyst Ratings
Wall Street analysts have issued reports on $GEHC in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 10/13/2025
To track analyst ratings and price targets for GE HEALTHCARE TECHNOLOGIES, check out Quiver Quantitative's $GEHC forecast page.
GE HEALTHCARE TECHNOLOGIES Price Targets
Multiple analysts have issued price targets for $GEHC recently. We have seen 5 analysts offer price targets for $GEHC in the last 6 months, with a median target of $83.0.
Here are some recent targets:
- Matt Miksic from Barclays set a target price of $86.0 on 10/13/2025
- Ryan Zimmerman from BTIG set a target price of $89.0 on 10/13/2025
- Joanne Wuensch from Citigroup set a target price of $83.0 on 10/07/2025
- Patrick Wood from Morgan Stanley set a target price of $74.0 on 07/31/2025
- Graham Doyle from UBS set a target price of $73.0 on 05/05/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
